English version
Nina Ånensen

Nina Ånensen

Vitenskapelige publikasjoner

Ånensen, Nina ; Hjelle, Sigrun Margrethe; Van, Belle Werner; Haaland, Ingvild; Silden, Elisabeth; Bourdon, Jean-Christophe; Hovland, Randi; Tasken, Kjetil; Knappskog, Stian; Lønning, Per Eystein; Bruserud, Øystein; Gjertsen, Bjørn Tore (2012). Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. Oncogene. Vol. 31.
https://doi.org/10.1038/onc.2011.348

Øyan, Anne Margrete; Ånensen, Nina ; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore (2009). Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. BMC Cancer. Vol. 9.
https://doi.org/10.1186/1471-2407-9-77

Ånensen, Nina ; Øyan, Anne Margrete; Huseby, Sjur; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore (2007). Early gene expression of acute myeloid leukemia in response to chemotherapy. Expert Review of Anticancer Therapy. Vol. 7.
https://doi.org/10.1586/14737140.7.5.741

Gjertsen, Bjørn Tore; Bredholt, Therese; Ånensen, Nina ; Vintermyr, Olav (2007). Bcl-2 antisense in the treatment of human malignancies: A delusion in targeted therapy. Current Pharmaceutical Biotechnology. Vol. 8.
https://doi.org/10.2174/138920107783018381

Irish, Jonathan C.; Ånensen, Nina ; Hovland, Randi; Skavland, Jørn; Børresen-Dale, Anne-Lise; Bruserud, Øystein; Nolan, Gary P; Gjertsen, Bjørn Tore (2007). Flt3 Y591 duplication and Bc1-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood. Vol. 109.
https://doi.org/10.1182/blood-2006-02-004234

Ersvær, Elisabeth; Zhang, Jian-Ying; McCormack, Emmet Martin; Olsnes, Astrid Marta; Ånensen, Nina ; Tan, Eng M.; Gjertsen, Bjørn Tore; Bruserud, Øystein (2007). Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. 16 s. European Journal of Haematology. Vol. 79.
https://doi.org/10.1111/j.1600-0609.2007.00899.x

Bruserud, Øystein; Stapnes, Camilla I; Tronstad, Karl Johan; Ryningen, Anita; Ånensen, Nina ; Gjertsen, Bjørn Tore (2006). Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML. Expert opinion on therapeutic targets. Vol. 10.
https://doi.org/10.1517/14728222.10.1.51

Ånensen, Nina ; Haaland, Ingvild; D Santos, Clive; Belle, Werner Van; Gjertsen, Bjørn Tore (2006). Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia. Current Pharmaceutical Biotechnology. Vol. 7.
https://doi.org/10.2174/138920106777549731

Ånensen, Nina ; Øyan, Anne Margrete; Bourdon, Jean-Christophe; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore (2006). A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. 8 s. Clinical Cancer Research. Vol. 12.
https://doi.org/10.1158/1078-0432.CCR-05-1970

Van Belle, Werner; Sjøholt, Gry; Ånensen, Nina ; Høgda, Kjell-Arild; Gjertsen, Bjørn Tore (2006). Adaptive contrast enhancement of two-dimensional electrophoretic protein gel images facilitates visualization, orientation and alignment. Electrophoresis. Vol. 27.
https://doi.org/10.1002/elps.200500925





Publikasjonslisten er hentet ut av Cristin. Listen kan være ufullstendig